Advertisement
Advertisement

VERA

VERA logo

Vera Therapeutics, Inc. Class A Common Stock

43.71
USD
Sponsored
-1.33
-2.95%
Apr 13, 16:00 UTC -4
Closed
exchange

Pre-Market

44.30

+0.59
+1.34%

Vera Therapeutics, Inc. Class A Common Stock Profile

About

Vera Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

Info & Links

CEO

Marshall Fordyce

Headquarters

2000 SIERRA POINT PARKWAY, SUITE 1200
BRISBANE, CA 94005, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.veratx.com

Auditor

KPMG LLP

Share holders

16

Employees

249

Vera Therapeutics, Inc. Class A Common Stock Statistics

Valuation Measures

Market Capitalization2

3.18B

Enterprise Value

2.90B

Enterprise Value/EBITDA(ttm)

-9.05

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.83

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-59.72%

Return on Invested Capital(ttm)

-53.29%

Return on Assets(ttm)

-49.10%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-320.13M

Net Income Available to Common(ttm)

-299.62M

Diluted EPS(ttm)

-4.66

Share Statistics

Beta (5Y Monthly)

1.17

52-Week Change

94.87%

S&P 500 52-Week Change

27.38%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

71.36M

Dividend Yield

0.00%

Float4

59.73M

% Held by Insiders

16.30%

% Held by Institutions

99.21%

Balance Sheet

Total Cash(mrq)

714.59M

Total Cash Per Share(mrq)

10.01

Total Debt(mrq)

74.84M

Total Debt/Equity(mrq)

12.38%

Current Ratio(mrq)

13.64%

Quick Ratio(mrq)

13.64%

Book Value Per Share(mrq)

8.48

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.75

Free Cash Flow(ytd)

-241.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement